Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma
Northwestern University
Northwestern University
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
InnoCare Pharma Inc.
Peter MacCallum Cancer Centre, Australia
Fondazione Italiana Linfomi - ETS
The First Affiliated Hospital of Soochow University
The First Affiliated Hospital with Nanjing Medical University
Tianjin Medical University Cancer Institute and Hospital
Sun Yat-sen University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Fujian Medical University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Korea Cancer Center Hospital
National Cancer Institute (NCI)
Heidelberg University
National Cancer Institute (NCI)
Medical University of Vienna